Our core focus is in the discovery, research and development of angiogenesis-based medicine. Angiogenesis-based medicine is a new, comprehensive approach to fighting diseases using new medical treatments that either inhibit or stimulate angiogenesis.
view more
			
			Eman biodiscoveries is offering new services from preclinical drug screening in vitro (cells) and in vivo (animal models) . Our drug screening services includes a variety of cancer cell lines. Eman Biodiscoveries is the only company in South East Asia that breeds a unique breed of mice (nude mice) that can host several human cancer diseases..
view more
 
 Eman Biodiscoveries has arranged the IBDC&EXPO2021 Borneo Convention Center, Kuching (BCCK), Sarawak, Malaysia on 27-30 Nov 2021 in associatio with NatureCeuticals that is supported by Sarawak Convention Buereau and Eman Research Australia.
Read Dr. Amin Malik Shah's Full Welcome
EARLY BIRD CALL FOR ABSTRACTS OPEN
                  Fri April 03, 2020 09:04 AM AEST
                  EARLY BIRD CALL FOR ABSTRACTS DEADLINE
Sun August 30, 2020 11:08 PM AEST
GENERAL CALL FOR ABSTRACTS
Fri April 03, 2020 12:04 AM AEST
CONFERENCE REGISTRATION OPENS
                  Wed April 01, 2020 09:04 AM AEST
                  EARLY BIRD REGISTRATION DEADLINE
                  Sat September 12, 2020 11:09 PM AEST
                  REGISTRATION CANCELLATION DEADLINE
              Fri February 26, 2021 11:02 PM AEST
			We serve as a convenient one stop solution to industries, research laboratories and universities focussing on drug research and development. EMAN Biodiscoveries provides R&D services from bench scale to pilot scale 
        right to production scale. This enables researchers to fully realise their R&D
        work right to commercial production. Our vast experience in this field can help
        researchers to avoid pitfalls that could hamper their research effort. In order to 
        fulfil our goals, we have established a number of organisations in Malaysia and 
        overseas to facilitate the commercialisation of our products and services.
1. R&D services
2. Commercialization
3. Regulatory application and safety testing
4. Herbal Standardization and Quaity control
5. Product formulation
6. Drug Discovery services
 
				From designing and performing animal studies to histopathology analysis and follow-up molecular biology and biochemistry experiments, our experienced staff work closely with our clients to ensure that we provide the in vivo services they need. Our modern animal facility includes suites dedicated to housing athymic mice and specialized surgical facility.
				Animal tissues recovered at the end of a study can be used in follow-up experiments including in vitro efficacy assessment, FACS analysis, Biochemical assays on treated tissues, Differential gene expression, RNA isolation, ELISA, and western blot on tissue lysates.
				HPLC Characterization, HPTLC Profiling and Phytomedicine
				expertise and equipment to perform customized screening for hit compounds.
							EMAN is at the forefront of regulatory compliant biological analysis and offers access to experienced personnel as well as cutting edge technology.
EMAN provides consultation services in the following : Patenting Formulation Development for oral use or topical applications. Commercialization and Marketing of Developed Products
							
							We can advice on and assist in assay development, i.e. optimizing, validating and downscaling the assay to 96-well plate format. After hit compound identification, services for further compound characterization can be provided, i.e. determining the LD50
In vivo testing services Biomechnical properties, viscoelasticity by running time measurement Cutaneous pH measurement Efficacy against Free Radicals Determination of sun protection factor and water resistance Testing for wound healing properties of extracts Development of skin care products and services
							© 2020 Eman Biodiscoveries Sdn. Bhd. | All rights reserved